Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA)
CUSIP: 55234L105
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 1,644,695
- Total 13F shares
- 5,133,990
- Share change
- -432,032
- Total reported value
- $22,384,742
- Price per share
- $4.36
- Number of holders
- 31
- Value change
- -$3,693,898
- Number of buys
- 11
- Number of sells
- 18
Quarterly Holders Quick Answers
What is CUSIP 55234L105?
CUSIP 55234L105 identifies LYRA - Lyra Therapeutics, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 55234L105:
Top shareholders of LYRA - Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
196%
|
3,222,560
|
$29,403,000 | — | 30 Sep 2021 | |
| Polaris Venture Management Co. V, L.L.C. |
13F
|
Company |
67%
|
1,100,852
|
$10,044,000 | — | 30 Sep 2021 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
32%
|
533,417
|
$4,867,000 | — | 30 Sep 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
25%
|
403,450
|
$3,688,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
13%
|
220,029
|
$2,008,000 | — | 30 Sep 2021 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
13%
|
215,576
|
$1,967,000 | — | 30 Sep 2021 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
8.5%
|
139,187
|
$1,272,000 | — | 30 Sep 2021 | |
| Parian Global Management LP |
13F
|
Company |
7.4%
|
121,300
|
$1,109,000 | — | 30 Sep 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
7.2%
|
118,158
|
$1,080,000 | — | 30 Sep 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
6.7%
|
110,511
|
$1,008,000 | — | 30 Sep 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
4.6%
|
76,352
|
$697,000 | — | 30 Sep 2021 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
4.2%
|
68,900
|
$630,000 | — | 30 Sep 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
3.5%
|
58,000
|
$529,000 | — | 30 Sep 2021 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
39,200
|
$358,000 | — | 30 Sep 2021 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
2.4%
|
39,167
|
$358,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
36,018
|
$329,000 | — | 30 Sep 2021 | |
| Pentwater Capital Management LP |
13F
|
Company |
1.9%
|
32,014
|
$292,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
1.8%
|
30,140
|
$275,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.1%
|
17,818
|
$163,000 | — | 30 Sep 2021 | |
| Ergoteles LLC |
13F
|
Company |
0.99%
|
16,273
|
$149,000 | — | 30 Sep 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.97%
|
15,895
|
$145,000 | — | 30 Sep 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.81%
|
13,384
|
$122,000 | — | 30 Sep 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.76%
|
12,457
|
$114,000 | — | 30 Sep 2021 | |
| Trexquant Investment LP |
13F
|
Company |
0.67%
|
11,085
|
$101,000 | — | 30 Sep 2021 | |
| TrinityBridge Ltd |
13F
|
Company |
0.43%
|
7,000
|
$64,000 | — | 30 Sep 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.26%
|
4,235
|
$38,000 | — | 30 Sep 2021 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.08%
|
1,234
|
$12,000 | — | 30 Sep 2021 | |
| Cardinal Capital Management, Inc. |
13F
|
Company |
0.04%
|
650
|
$6,000 | — | 30 Sep 2021 | |
| Laurel Wealth Advisors LLC |
13F
|
Company |
0.03%
|
500
|
$5,000 | — | 30 Sep 2021 | |
| US BANCORP \DE\ |
13F
|
Company |
0.03%
|
500
|
$5,000 | — | 30 Sep 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
500
|
$5,000 | — | 30 Sep 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.02%
|
287
|
$3,000 | — | 30 Sep 2021 | |
| HARBOUR INVESTMENTS, INC. |
13F
|
Company |
0.01%
|
175
|
$2,000 | — | 30 Sep 2021 | |
| Koshinski Asset Management, Inc. |
13F
|
Company |
0.01%
|
200
|
$1,825 | — | 30 Sep 2021 |
Institutional Holders of Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA) as of Q4 2021
As of 31 Dec 2021,
Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,133,990 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, PURA VIDA INVESTMENTS, LLC, Ikarian Capital, LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, BANK OF AMERICA CORP /DE/, Pentwater Capital Management LP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Clearline Capital LP, and TWO SIGMA ADVISERS, LP.
This page lists
31
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
33
Q4 2021 holders
31
Holder diff
-2
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.